DXCM241122P69000
- 0.05
- 0.000.00%
DexCom Newsroom
Is DexCom, Inc. (NASDAQ:DXCM) Potentially Undervalued?
Why Is DexCom, Inc. (DXCM) Among the Worst Performing Healthcare Stocks in 2024?
DexCom, Inc. (DXCM): Innovation and Growth Catalysts Amid Strong Long-Term Outlook for Diabetes Care
BofA Securities Maintains DexCom(DXCM.US) With Buy Rating
Australia Diabetes Market Forecasts and Company Analysis 2024-2032, Novo Nordisk, Eli Lilly, Roche, Abbott Laboratories, Insuletn, Dexcom, Medtronic, Ypsomed
Express News | Dexcom Inc : Leerink Partners Cuts Target Price to $86 From $87
Dexcom's G7 Hospital CGM Poised for Market Breakthrough With NTAP and FDA Approvals
Here's Why DexCom (DXCM) Declined In Q3
Wells Fargo Maintains DexCom(DXCM.US) With Buy Rating, Maintains Target Price $90
Wells Fargo Sticks to Its Buy Rating for Dexcom (DXCM)
These 10 Laggard Stocks Could Get Hit Further by Tax-Loss Selling
DexCom Pairs Its Glucose Monitor With Oura's Smart Ring -- Barrons.com
DexCom, ŌURA Enter Strategic Partnership; Dexcom Is Investing $75M In Ōura Series D Funding
Oura Valued at $5 Billion in Deal With Glucose Device Maker Dexcom
Dexcom and ŌURA Announce Strategic Partnership
Express News | Dexcom: Co, Ōura Announce Partnership to Enable Two-Way Data Flow Between Co's Glucose Biosensors and Apps and Oura Ring and App
Express News | Dexcom: Investing $75 Mln in Ōura Series D Funding, With Ōura Now Valued Over $5 Bln
Express News | Dexcom: Co, Ōura to Co-Market, Cross-Sell Each Other’s Products; First App Integration Expected to Launch in H1 2025
S&P Sees Some Signs of a US Credit Bubble as Spreads Tighten
Dexcom Insider Sold Shares Worth $264,285, According to a Recent SEC Filing